Fetal dose from proton pencil beam scanning craniospinal irradiation during pregnancy: a Monte Carlo study
- 28 January 2022
- journal article
- research article
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 67 (3) , 035003
Abstract
Objective . We conducted a Monte Carlo study to comprehensively investigate the fetal dose resulting from proton pencil beam scanning (PBS) craniospinal irradiation (CSI) during pregnancy. Approach . The gestational-age dependent pregnant phantom series developed at the University of Florida (UF) were converted into DICOM-RT format (CT images and structures) and imported into a treatment planning system (TPS) (Eclipse v15.6) commissioned to a IBA PBS nozzle. A proton PBS CSI plan (prescribed dose: 36 Gy) was created on the phantoms. The TOPAS MC code was used to simulate the proton PBS CSI on the phantoms, for which MC beam properties at the nozzle exit (spot size, spot divergence, mean energy, and energy spread) were matched to IBA PBS nozzle beam measurement data. We calculated mean absorbed doses for 28 organs and tissues and whole body of the fetus at eight gestational ages (8, 10, 15, 20, 25, 30, 35, and 38 weeks). For contextual purposes, the fetal organ/tissue doses from the treatment planning CT scan of the mother’s head and torso were estimated using the National Cancer Institute dosimetry system for CT (NCICT, Version 3) considering a low-dose CT protocol (CTDIvol: 8.97 mGy). Main results . The majority of the fetal organ/tissue doses from the proton PBS CSI treatment fell within a range of 3–6 mGy. The fetal organ/tissue doses for the 38 week phantom showed the largest variation with the doses ranging from 2.9 mGy (adrenals) to 8.2 mGy (eye lenses) while the smallest variation ranging from 3.2 mGy (oesophagus) to 4.4 mGy (brain) was observed for the doses for the 20 week phantom. The fetal whole-body dose ranged from 3.7 mGy (25 weeks) to 5.8 mGy (8 weeks). Most of the fetal doses from the planning CT scan fell within a range of 7–13 mGy, approximately 2-to-9 times lower than the fetal dose equivalents of the proton PBS CSI treatment (assuming a quality factor of 7). Significance . The fetal organ/tissue doses observed in the present work will be useful for one of the first clinically informative predictions on the magnitude of fetal dose during proton PBS CSI during pregnancy.Keywords
This publication has 33 references indexed in Scilit:
- TOPAS: An innovative proton Monte Carlo platform for research and clinical applicationsMedical Physics, 2012
- Review of Radiation Therapy in the Pregnant Cancer PatientClinical Obstetrics and Gynecology, 2011
- The UF family of hybrid phantoms of the developing human fetus for computational radiation dosimetryPhysics in Medicine & Biology, 2011
- Better radiation weighting factors for neutrons generated from proton treatment are neededRadiation Protection Dosimetry, 2010
- The UF family of reference hybrid phantoms for computational radiation dosimetryPhysics in Medicine & Biology, 2009
- A review of dosimetry studies on external-beam radiation treatment with respect to second cancer inductionPhysics in Medicine & Biology, 2008
- A boundary-representation method for designing whole-body radiation dosimetry models: pregnant females at the ends of three gestational periods—RPI-P3, -P6 and -P9Physics in Medicine & Biology, 2007
- Intensity-modulated radiation therapy, protons, and the risk of second cancersInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Relative biological effectiveness (RBE), quality factor ( Q ), and radiation weighting factor ( w R )Annals of the ICRP, 2003
- Basic anatomical and physiological data for use in radiological protection: reference valuesAnnals of the ICRP, 2002